跳至主要内容
临床试验/CTRI/2022/12/047998
CTRI/2022/12/047998招募中未知

Analysis of minimal detectable change (MDC) and minimal clinically importantdifference (MCID) of Bruininks Oseretsky Test (BOT-2) balance component inpatients with cerebral palsy: A Cross Sectional Analytical Study.

ABHIJIT SATRALKAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Diagnosed spastic diplegic cerebral palsy
  • Children willing to paticipate in study
  • GMFC LEVEL 1 TO 3
  • Spasticity Grade 1 AND 1 PLUS ON MODIFIED ASHWORTH SCALE
  • Able to stand for one minute with or without support
  • able to understand & execute commands given by the assessor

排除标准

  • Children who had taken any treatment for motor deficits in the previous 6 months
  • Children having any major co-morbid medical problems such as moderate to severe mental disability, profound visual or hearing impairment, or had any major behavioural problems
  • Children falling into average, below average, and well below average descriptive categories on bot 2
  • Children having BMI in the obese range.
  • Any major trauma or fractures in the past 2 years.
  • Children unable to understand the procedure of the study.
  • GMFC level IV & V,
  • Progressive neurological disorder, genetic or metabolic disorder, or severe concurrent illness or disease not typically associated with cp (e.g., traumatic brain injury or active pneumonia).

研究者

发起方
ABHIJIT SATRALKAR

相似试验